REGENERON PHARMACEUTICALS, INC.
Q4 2025 13F Holdings
- Locationtarrytown, NY
- Num holdings
2
- Value ($000)
$33,799
- Date Filed 02/06/2026
- Form type13F-HR
- CIK 0000872589
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
Intellia Therapeutics, Inc. | COMMON STOCK | 45826J105 | $33.29M | 99 % | 3,702,995 | ||
Adicet Bio, Inc. | COMMON STOCK | 007002108 | $509.5K | 2 % | 60,511 |
Rows Per Page
10
- 10
- 50
- 100